ChemPartner PharmaTech Co

ChemPartner PharmaTech Co ROE

The Return on Equity (ROE) of ChemPartner PharmaTech Co (300149.SZ) as of Oct 27, 2026 is 1.05 %. In the previous year, Return on Equity (ROE) was -18.66 % — a change of -105.63% (higher).

ROE

1.05 %

YoY

-105.63%

Last updated:

In 2025, ChemPartner PharmaTech Co's return on equity (ROE) was 1.05 %, a -105.63% increase from the -18.66 % ROE in the previous year.

The ChemPartner PharmaTech Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
7.36 CNY
Jan 1, 2019
6.06 CNY
Jan 1, 2020
6.37 CNY
Jan 1, 2021
-20.48 CNY
Jan 1, 2022
16.03 CNY
Jan 1, 2023
-63.81 CNY
Jan 1, 2024
-18.66 CNY
Jan 1, 2025
1.05 CNY
The ChemPartner PharmaTech Co ROE history
YEARROEYoY
1.05 %-105.63%
-18.66 %-70.76%
-63.81 %-498.05%
16.03 %-178.29%
-20.48 %-421.67%
6.37 %+5.02%
6.06 %-17.59%
7.36 %+3.26%
7.12 %-15.61%
8.44 %+2.72%
8.22 %+36.33%
6.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ChemPartner PharmaTech Co Stock analysis

What does ChemPartner PharmaTech Co do? ChemPartner PharmaTech Co., Ltd. generates revenue through the research, development, production, and sale of prebiotic products, primarily fructooligosaccharides and galactooligosaccharides. The company markets its products under the brand names FOS and GOS, targeting the nutrition and health, dairy, beverage, bakery, and functional snack food industries. Domestic distribution dominates, with South China as the core market, serving manufacturers of food and health products. The firm's product portfolio focuses on fructooligosaccharides and galactooligosaccharides, sold as FOS and GOS, which are integrated into various consumer goods. These prebiotics are essential ingredients in dairy, beverages, baked goods, and functional snacks, meeting demand from food producers seeking health-enhancing additives. South China remains the primary sales region, aligning with the company's domestic market strategy. ChemPartner PharmaTech's revenue streams derive from B2B sales to food and beverage manufacturers, particularly those producing nutrition and health products, dairy, and functional snacks. The company's brands FOS and GOS are positioned as key ingredients for health-focused consumer goods, with sales concentrated in South China, the main market for its domestic distribution network. ChemPartner PharmaTech Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding ChemPartner PharmaTech Co's Return on Equity (ROE)

ChemPartner PharmaTech Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing ChemPartner PharmaTech Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

ChemPartner PharmaTech Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in ChemPartner PharmaTech Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about ChemPartner PharmaTech Co stock

Return on Equity (ROE) of ChemPartner PharmaTech Co is 1.05 % in 2025.

Return on Equity (ROE) of ChemPartner PharmaTech Co changed from -18.66 % to 1.05 %, representing a -105.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) ChemPartner PharmaTech Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s ChemPartner PharmaTech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ChemPartner PharmaTech Co

All Key Metrics — ChemPartner PharmaTech Co